: Treatment-resistant depression (TRD) is a severe disorder characterized by high relapse rates and decreased quality of life. An effective strategy in the management of TRD is deep brain stimulation (DBS), a technique consisting of the implantation of electrodes that receive a stimulation via a pacemaker-like stimulator into specific brain areas, detected through neuroimaging investigations, which include the subgenual cingulate cortex (sgCC), basal ganglia, and forebrain bundles. In this context, to improve our understanding of the mechanism underlying the antidepressant effects of DBS in TRD, we collected the results of diffusion tensor imaging (DTI) studies exploring how WM microstructure is associated with the therapeutic effects of DB...
Background Deep brain stimulation (DBS) represents an alternative symptomatic treatment for major de...
Background: Deep brain stimulation (DBS) is an innovative treatment for treatment-refractory depress...
Background: Psychotherapy has demonstrated comparable efficacy to antidepressant medication in the t...
BACKGROUND: Deep brain stimulation (DBS) of the subcallosal cingulate white matter (SCCwm) or anteri...
Objective: Deep brain stimulation (DBS) has been used as a treatment of last resort for treatment-re...
BACKGROUND: Depressed mood, anhedonia, psychomotor retardation and alterations of circadian rhyth...
Background: Patients with treatment-resistant depression (TRD) commonly report significant disabilit...
SummaryTreatment-resistant depression is a severely disabling disorder with no proven treatment opti...
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depr...
Major Depressive Disorder (MDD) is characterized by the persistent presence of at least fivedepressi...
Background: Major Depressive Disorder (MDD) is a burdensome and highly recurrent disorder, with a he...
Background: Patients with treatment-resistant depression (TRD) commonly report significant disabilit...
BACKGROUND: Deep brain stimulation (DBS) represents an alternative symptomatic treatment for major d...
Background: Major depressive disorder is a debilitating psychiatric condition with high rates of tre...
To investigate white matter volume abnormalities in patients with major depression and the effects o...
Background Deep brain stimulation (DBS) represents an alternative symptomatic treatment for major de...
Background: Deep brain stimulation (DBS) is an innovative treatment for treatment-refractory depress...
Background: Psychotherapy has demonstrated comparable efficacy to antidepressant medication in the t...
BACKGROUND: Deep brain stimulation (DBS) of the subcallosal cingulate white matter (SCCwm) or anteri...
Objective: Deep brain stimulation (DBS) has been used as a treatment of last resort for treatment-re...
BACKGROUND: Depressed mood, anhedonia, psychomotor retardation and alterations of circadian rhyth...
Background: Patients with treatment-resistant depression (TRD) commonly report significant disabilit...
SummaryTreatment-resistant depression is a severely disabling disorder with no proven treatment opti...
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depr...
Major Depressive Disorder (MDD) is characterized by the persistent presence of at least fivedepressi...
Background: Major Depressive Disorder (MDD) is a burdensome and highly recurrent disorder, with a he...
Background: Patients with treatment-resistant depression (TRD) commonly report significant disabilit...
BACKGROUND: Deep brain stimulation (DBS) represents an alternative symptomatic treatment for major d...
Background: Major depressive disorder is a debilitating psychiatric condition with high rates of tre...
To investigate white matter volume abnormalities in patients with major depression and the effects o...
Background Deep brain stimulation (DBS) represents an alternative symptomatic treatment for major de...
Background: Deep brain stimulation (DBS) is an innovative treatment for treatment-refractory depress...
Background: Psychotherapy has demonstrated comparable efficacy to antidepressant medication in the t...